Site Search
Search Results
Survivor Views of Pharmacogenomic Testing
... at all levels of government. Fielded June 26-July 19, 2023, our latest survey explores awareness of and attitudes toward pharmacogenomic (PGx) testing, a form of genetic testing to better understand a patient’s risk for drug reactions. The web-based survey was conducted among 1,155n cancer patients and survivors ... same drug. These differences may impact the effectiveness of a drug or the side effects a person may experience. (Note: this is different from biomarker testing of a tumor to help determine which drug may be used) Four-in-Ten Aware of PGx Testing Based on the definition above, 42% of ...
Priority Issue
State
Policy Issue
- (-) Remove Patient Quality of Life filter Patient Quality of Life